Drugmakers raised list prices by an average of 6.6% in the first few weeks of this year on cancer, diabetes and other prescription medicines, sticking with more moderate increases while lawmakers scrutinize pricing practices.
In all, about 150 drugmakers raised prices on 866 products in the U.S. through Jan. 20, according to an analysis from Rx Savings Solutions, which sells software to help employers and health plans choose the least-expensive medicines.
Drugmakers often raise prices of their products during the first few weeks of a new year.
After taking double-digit increases several years ago, many drugmakers pledged to moderate price increases in response to political pressure and the specter of Congress imposing regulations to rein in their pricing power.
Many companies say they don’t realize all or any of the benefit from…
